Brief: TherapeuticsMD Reports Q4 And Full Year 2020 Results
March 2 (Reuters) - TherapeuticsMD Inc TXMD.O :
* THERAPEUTICSMD ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2020
FINANCIAL RESULTS
* Q4 LOSS PER SHARE $0.15
* Q4 EARNINGS PER SHARE ESTIMATE $-0.11 -- REFINITIV IBES
DATA
* FINANCING AGREEMENT AMENDED TO UPDATE MINIMUM NET REVENUE
COVENANTS FOR REMAINDER OF LOAN; TO PAY DOWN $50 MILLION IN DEBT
Source text for Eikon: ID:nBwbd7mZJa
Further company coverage: TXMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TherapeuticsMD
See all newsBrief: TherapeuticsMD Announces First Quarter 2026 Financial Results
TherapeuticsMD swings to Q1 net income as license revenue rises
TherapeuticsMD swings to Q3 profit, license revenue climbs
Brief: TherapeuticsMD Q1 Operating Expenses USD 1.264 Million
Brief: Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract